noxafil oral suspension 40 mgml
msd pharma (singapore) pte. ltd. - posaconazole - suspension - 40mg/ml - posaconazole 40mg/ml
noxafil 100mg modified release tablet
merck sharp & dohme (malaysia) sdn bhd - posaconazole -
noxafil 100mg modified release tablet
merck sharp & dohme (malaysia) sdn bhd - posaconazole -
posatex veterinary
intervet ( israel) ltd - mometasone furoate (as monohydrate); orbifloxacin; posaconazole - ear drops suspension - orbifloxacin 8.5 mg/ml; mometasone furoate (as monohydrate) 0.9 mg/ml; posaconazole 0.9 mg/ml - dogs: treatment of acute otitis externa and acute exacerbations of recurrent otitis externa, associated with bacteria susceptible to orbifloxacin and fungi susceptible to posaconazole, in particular malassezia pachydermatis
posaconazole teva 100 mg gastro-resist. tabl.
teva b.v. - posaconazol 100 mg - gastro-resistant tablet - posaconazole
posaconazole teva 100 mg gastro-resist. tabl.
teva b.v. - posaconazol 100 mg - gastro-resistant tablet - posaconazole
posatex
schering-plough animal health limited - mometasone furoate monohydrate; posaconazole; orbifloxacin - mometasone furoate monohydrate 1 g/kg; posaconazole 1 g/kg; orbifloxacin 10 g/kg - antibiotic
noxafil tablet 100mg
msd pharma (singapore) pte. ltd. - posaconazole - tablet, delayed release - posaconazole 100mg
noxafil
merck sharp & dohme australia pty ltd - posaconazole -
chromsystems chromsystems itraconazole posaconazole voriconazole in serumplasma
scientific resources pte ltd - general hospital - the chromsystems itraconazole, posaconazole, voriconazole in serum/plasma is an in vitro diagnostic device to be used in clinical laboratories for the quantitative detection of itraconazole, hydroxyitraconazole, posaconazole and voriconazole in human serum or plasma samples via high performance liquid chromatography (hplc). it is intended as a monitoring test for patients treated with one or more antimycotic drugs listed above as an aid to ensure drug levels are maintained within the therapeutic range.